<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03266029</url>
  </required_header>
  <id_info>
    <org_study_id>CA001</org_study_id>
    <nct_id>NCT03266029</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Cordio App in Adult Patients With CHF</brief_title>
  <official_title>Single-Arm Observational Double - Blind Study Designed to Clinically Evaluate Cordio Application in Adult Patients With CHF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordio Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordio Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study on CHF patients at one site in Israel. After signing informed consent and
      undergoing screening assessments, eligible patients will record a sentence and/or counting
      into a smartphone and/or recording machine. The app will upload the vocal data to the
      sponsor's servers for analysis.The study will include a screening phase in the hospital,
      according to the inclusion and exclusion criteria. After signing informed consent and
      undergoing screening assessments, eligible patients will record a sentence and/or counting
      into a recording machine. The patient will record at hospital admittance, during
      hospitalization and at release. Before hospital release, if applicable, an app will be
      installed in their smart phone in order to continue the recording at home.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 24, 2015</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vocal parameters</measure>
    <time_frame>6 months following hospitalization</time_frame>
    <description>fundamental frequency in Hz</description>
  </primary_outcome>
  <enrollment type="Actual">89</enrollment>
  <condition>Congestive Heart Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cordio App</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitals/ CHF clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of NYHA Class II or III HF.

          -  In hospital after Heart Failure Related (HFR) hospitalization.

          -  Able to understand and provide written informed consent.

        Exclusion Criteria:

          -  Subjects unable to comply with the daily use of the application due to mental
             disorders.

          -  Subjects who have had a major cardiovascular event within 2 months of Screening Visit.

          -  GFR &lt;25 ml/min who are non-responsive to diuretic therapy or who are on chronic renal
             dialysis.

          -  Women who are pregnant or lactating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Zaher Azzam, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Facility</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rambam Health Care Facility</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>August 19, 2017</study_first_submitted>
  <study_first_submitted_qc>August 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2017</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

